DrugDashboards

Ertapenem Sodium

Ertapenem · ERTAPENEM SODIUM 1 g/1 · Injection, Powder, Lyophilized, For Solution · Intramuscular; Intravenous · Dr.Reddys Laboratories Inc.,

NDC 43598-0901-58 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 22% over the past year, to $27.76 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$27.76per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$6.75per billing unit (500 MG)HCPCS J1335 · Jul 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$20.00$40.00$60.00Jun 2023Sep 2026$27.76
32 price points · per EASource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$1,000.00
Reported to Texas DSHS · 2026 annual filing · Dr. Reddy's Laboratories, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 500 MG
$6.750
HCPCS J1335 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$641,668
3,716 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

15Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 4 active manufacturers+5
  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for ertapenem (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA212040
TE code
AP
Approval date
Mar 26, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ertapenem (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Dr.Reddys Laboratories Inc.,ERTAPENEM SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
Hospira, Inc.ERTAPENEM SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCERTAPENEM SODIUM 1 g/1Jul 15, 2026Sep 2, 2026
WG Critical Care, LLCERTAPENEM SODIUM 1 g/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ertapenem Sodium — NDC 43598-0901-58," retrieved September 3, 2026, https://drugdashboards.com/drug/43598090158.

Free to cite with attribution — see how the data is put together.